126 results
S-3ASR
EX-4.8
BCRX
Biocryst Pharmaceuticals Inc.
27 Feb 24
Automatic shelf registration
5:05pm
securities, or retain in accordance with its standard retention policy, all Securities surrendered for registration of transfer, exchange, redemption
DEFA14A
pqa9s8lwkvbwzq14viah
26 May 22
Additional proxy soliciting materials
5:00pm
8-K
EX-99.1
221vi
10 Jan 22
Results of Operations and Financial Condition
7:04am
8-K
EX-99.1
2huhj2yc
3 Nov 21
BioCryst Reports Third Quarter 2021 Financial Results and Upcoming Key Milestones
7:04am
424B5
i3zdghknz487jq
9 Aug 21
Prospectus supplement for primary offering
4:03pm